Gilead CEO Daniel O'Day attends a meeting with the President and other biopharma leaders at the White House on March 2, 2020 (AP Photo)
Ramping up global production of remdesivir, Gilead CEO Dan O’Day details plans to distribute 1.5M doses to fight Covid-19 — for free
Gilead is still some days away from turning the card on its first round of data on remdesivir’s ability to fight severe cases of Covid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
